Psychedelic Therapy: Why so many patients are asking for the option

The federal government is fast-tracking some psychedelic-based medicines for research and development. Emergency physician Dr. Jonathan Leak explains how these therapies may work in the brain and if they’re safe.

00:00 — Fire captain recounts suicidal crisis; psilocybin changes his outlook and family life
00:36 — Intro: what psychedelics might do (neurotransmitters/neuroplasticity) and the safety question
00:54 — Why now: executive order to speed development; focus on treatment-resistant depression, PTSD, addiction
01:23 — Arizona psilocybin trial for first responders; content warning for sensitive topics
02:05 — Mark Herman’s story: chronic trauma, “fight or flight,” and seeking relief
03:01 — Research barriers from past criminalization; trial details and demand/waitlist
04:22 — Career risks/stigma for officers; underground use; dosing and safety concerns
05:01 — Black market concerns; funding push; hopes for right-to-try and guardrails as access expands
07:20 — Interview begins: Dr. Leak’s credentials; ketamine currently used in psychedelic therapy
08:15 — What drugs are discussed: psilocybin, ibogaine, methylone/MDMA
09:00 — Evidence/history; why these may help PTSD, depression, addiction
10:53 — How they may work: receptors + neuroplasticity + psychedelic experience; importance of therapy integration
12:36 — Brain connectivity shifts; new pathways; how psilocybin is dosed and how long sessions last
15:01 — Patents/formulations; molecule tweaks vs process patents
16:02 — MDMA/methylone differences; trauma processing and study outcomes; need for certified care
18:08 — Clinic model questions; side effects, monitoring, and scaling sessions safely

The Wellness Files is a health-focused podcast where we explore practical tools, research and real patient stories. We hope to inform, inspire, and connect to audiences so you can be the best version of yourself, while also asking tough questions about safety and effectiveness.